1 Physostigmine Market Overview 1.1 Physostigmine Product Overview 1.2 Physostigmine Market Segment by Type 1.2.1 Intravenous 1.2.2 Intramuscular 1.2.3 Ophthalmic 1.3 Global Physostigmine Market Size by Type 1.3.1 Global Physostigmine Market Size Overview by Type (2016-2027) 1.3.2 Global Physostigmine Historic Market Size Review by Type (2016-2021) 1.3.2.1 Global Physostigmine Sales Breakdown in Volume by Type (2016-2021) 1.3.2.2 Global Physostigmine Sales Breakdown in Value by Type (2016-2021) 1.3.2.3 Global Physostigmine Average Selling Price (ASP) by Type (2016-2021) 1.3.3 Global Physostigmine Forecasted Market Size by Type (2022-2027) 1.3.3.1 Global Physostigmine Sales Breakdown in Volume by Type (2022-2027) 1.3.3.2 Global Physostigmine Sales Breakdown in Value by Type (2022-2027) 1.3.3.3 Global Physostigmine Average Selling Price (ASP) by Type (2022-2027) 1.4 Key Regions Market Size Segment by Type 1.4.1 North America Physostigmine Sales Breakdown by Type (2016-2021) 1.4.2 Europe Physostigmine Sales Breakdown by Type (2016-2021) 1.4.3 Asia-Pacific Physostigmine Sales Breakdown by Type (2016-2021) 1.4.4 Latin America Physostigmine Sales Breakdown by Type (2016-2021) 1.4.5 Middle East and Africa Physostigmine Sales Breakdown by Type (2016-2021) 2 Global Physostigmine Market Competition by Company 2.1 Global Top Players by Physostigmine Sales (2016-2021) 2.2 Global Top Players by Physostigmine Revenue (2016-2021) 2.3 Global Top Players Physostigmine Price (2016-2021) 2.4 Global Top Manufacturers Physostigmine Manufacturing Base Distribution, Sales Area, Product Type 2.5 Physostigmine Market Competitive Situation and Trends 2.5.1 Physostigmine Market Concentration Rate (2016-2021) 2.5.2 Global 5 and 10 Largest Manufacturers by Physostigmine Sales and Revenue in 2020 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Physostigmine as of 2020) 2.7 Date of Key Manufacturers Enter into Physostigmine Market 2.8 Key Manufacturers Physostigmine Product Offered 2.9 Mergers & Acquisitions, Expansion 3 Physostigmine Status and Outlook by Region 3.1 Global Physostigmine Market Size and CAGR by Region: 2016 VS 2021 VS 2026 3.2 Global Physostigmine Historic Market Size by Region 3.2.1 Global Physostigmine Sales in Volume by Region (2016-2021) 3.2.2 Global Physostigmine Sales in Value by Region (2016-2021) 3.2.3 Global Physostigmine Sales (Volume & Value) Price and Gross Margin (2016-2021) 3.3 Global Physostigmine Forecasted Market Size by Region 3.3.1 Global Physostigmine Sales in Volume by Region (2022-2027) 3.3.2 Global Physostigmine Sales in Value by Region (2022-2027) 3.3.3 Global Physostigmine Sales (Volume & Value), Price and Gross Margin (2022-2027) 4 Global Physostigmine by Application 4.1 Physostigmine Market Segment by Application 4.1.1 Hospital 4.1.2 Drug Store 4.2 Global Physostigmine Market Size by Application 4.2.1 Global Physostigmine Market Size Overview by Application (2016-2027) 4.2.2 Global Physostigmine Historic Market Size Review by Application (2016-2021) 4.2.2.1 Global Physostigmine Sales Breakdown in Volume, by Application (2016-2021) 4.2.2.2 Global Physostigmine Sales Breakdown in Value, by Application (2016-2021) 4.2.2.3 Global Physostigmine Average Selling Price (ASP) by Application (2016-2021) 4.2.3 Global Physostigmine Forecasted Market Size by Application (2022-2027) 4.2.3.1 Global Physostigmine Sales Breakdown in Volume, by Application (2022-2027) 4.2.3.2 Global Physostigmine Sales Breakdown in Value, by Application (2022-2027) 4.2.3.3 Global Physostigmine Average Selling Price (ASP) by Application (2022-2027) 4.3 Key Regions Market Size Segment by Application 4.3.1 North America Physostigmine Sales Breakdown by Application (2016-2021) 4.3.2 Europe Physostigmine Sales Breakdown by Application (2016-2021) 4.3.3 Asia-Pacific Physostigmine Sales Breakdown by Application (2016-2021) 4.3.4 Latin America Physostigmine Sales Breakdown by Application (2016-2021) 4.3.5 Middle East and Africa Physostigmine Sales Breakdown by Application (2016-2021) 5 North America Physostigmine by Country 5.1 North America Physostigmine Historic Market Size by Country 5.1.1 North America Physostigmine Sales in Volume by Country (2016-2021) 5.1.2 North America Physostigmine Sales in Value by Country (2016-2021) 5.2 North America Physostigmine Forecasted Market Size by Country 5.2.1 North America Physostigmine Sales in Volume by Country (2022-2027) 5.2.2 North America Physostigmine Sales in Value by Country (2022-2027) 6 Europe Physostigmine by Country 6.1 Europe Physostigmine Historic Market Size by Country 6.1.1 Europe Physostigmine Sales in Volume by Country (2016-2021) 6.1.2 Europe Physostigmine Sales in Value by Country (2016-2021) 6.2 Europe Physostigmine Forecasted Market Size by Country 6.2.1 Europe Physostigmine Sales in Volume by Country (2022-2027) 6.2.2 Europe Physostigmine Sales in Value by Country (2022-2027) 7 Asia-Pacific Physostigmine by Region 7.1 Asia-Pacific Physostigmine Historic Market Size by Region 7.1.1 Asia-Pacific Physostigmine Sales in Volume by Region (2016-2021) 7.1.2 Asia-Pacific Physostigmine Sales in Value by Region (2016-2021) 7.2 Asia-Pacific Physostigmine Forecasted Market Size by Region 7.2.1 Asia-Pacific Physostigmine Sales in Volume by Region (2022-2027) 7.2.2 Asia-Pacific Physostigmine Sales in Value by Region (2022-2027) 8 Latin America Physostigmine by Country 8.1 Latin America Physostigmine Historic Market Size by Country 8.1.1 Latin America Physostigmine Sales in Volume by Country (2016-2021) 8.1.2 Latin America Physostigmine Sales in Value by Country (2016-2021) 8.2 Latin America Physostigmine Forecasted Market Size by Country 8.2.1 Latin America Physostigmine Sales in Volume by Country (2022-2027) 8.2.2 Latin America Physostigmine Sales in Value by Country (2022-2027) 9 Middle East and Africa Physostigmine by Country 9.1 Middle East and Africa Physostigmine Historic Market Size by Country 9.1.1 Middle East and Africa Physostigmine Sales in Volume by Country (2016-2021) 9.1.2 Middle East and Africa Physostigmine Sales in Value by Country (2016-2021) 9.2 Middle East and Africa Physostigmine Forecasted Market Size by Country 9.2.1 Middle East and Africa Physostigmine Sales in Volume by Country (2022-2027) 9.2.2 Middle East and Africa Physostigmine Sales in Value by Country (2022-2027) 10 Company Profiles and Key Figures in Physostigmine Business 10.1 Alcon 10.1.1 Alcon Corporation Information 10.1.2 Alcon Introduction and Business Overview 10.1.3 Alcon Physostigmine Sales, Revenue and Gross Margin (2016-2021) 10.1.4 Alcon Physostigmine Products Offered 10.1.5 Alcon Recent Development 10.2 Akorn 10.2.1 Akorn Corporation Information 10.2.2 Akorn Introduction and Business Overview 10.2.3 Akorn Physostigmine Sales, Revenue and Gross Margin (2016-2021) 10.2.4 Alcon Physostigmine Products Offered 10.2.5 Akorn Recent Development 10.3 IFET 10.3.1 IFET Corporation Information 10.3.2 IFET Introduction and Business Overview 10.3.3 IFET Physostigmine Sales, Revenue and Gross Margin (2016-2021) 10.3.4 IFET Physostigmine Products Offered 10.3.5 IFET Recent Development 10.4 Merck 10.4.1 Merck Corporation Information 10.4.2 Merck Introduction and Business Overview 10.4.3 Merck Physostigmine Sales, Revenue and Gross Margin (2016-2021) 10.4.4 Merck Physostigmine Products Offered 10.4.5 Merck Recent Development 10.5 Hangzhou APIChem 10.5.1 Hangzhou APIChem Corporation Information 10.5.2 Hangzhou APIChem Introduction and Business Overview 10.5.3 Hangzhou APIChem Physostigmine Sales, Revenue and Gross Margin (2016-2021) 10.5.4 Hangzhou APIChem Physostigmine Products Offered 10.5.5 Hangzhou APIChem Recent Development 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 11.1 Physostigmine Key Raw Materials 11.1.1 Key Raw Materials 11.1.2 Key Raw Materials Price 11.1.3 Raw Materials Key Suppliers 11.2 Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Physostigmine Industrial Chain Analysis 11.4 Physostigmine Market Dynamics 11.4.1 Industry Trends 11.4.2 Market Drivers 11.4.3 Market Challenges 11.4.4 Market Restraints 12 Market Strategy Analysis, Distributors 12.1 Sales Channel 12.2 Physostigmine Distributors 12.3 Physostigmine Downstream Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.1.1 Research Programs/Design 14.1.1.2 Market Size Estimation 14.1.1.3 Market Breakdown and Data Triangulation 14.1.2 Data Source 14.1.2.1 Secondary Sources 14.1.2.2 Primary Sources 14.2 Author Details 14.3 Disclaimer

List of Tables Table 1. Major Company of Intravenous Table 2. Major Company of Intramuscular Table 3. Major Company of Ophthalmic Table 4. Global Physostigmine Sales by Type 2016 VS 2021 VS 2027 (US$ Million) Table 5. Global Physostigmine Sales by Type (2016-2021) & (K Units) Table 6. Global Physostigmine Sales Market Share in Volume by Type (2016-2021) Table 7. Global Physostigmine Sales by Type (2016-2021) & (US& Million) Table 8. Global Physostigmine Market Share in Value by Type (2016-2021) Table 9. Global Physostigmine Price by Type (2016-2021) & (US$/Unit) Table 10. Global Physostigmine Sales by Type (2022-2027) & (K Units) Table 11. Global Physostigmine Sales Market Share in Volume by Type (2022-2027) Table 12. Global Physostigmine Sales by Type (2022-2027) & (US$ Million) Table 13. Global Physostigmine Sales Market Share in Value by Type (2022-2027) Table 14. Global Physostigmine Price by Type (2022-2027) & (US$/Unit) Table 15. North America Physostigmine Sales by Type (2016-2021) & (K Units) Table 16. North America Physostigmine Sales by Type (2016-2021) & (US$ Million) Table 17. Europe Physostigmine Sales (K Units) by Type (2016-2021) Table 18. Europe Physostigmine Sales by Type (2016-2021) & (US$ Million) Table 19. Asia-Pacific Physostigmine Sales (K Units) by Type (2016-2021) Table 20. Asia-Pacific Physostigmine Sales by Type (2016-2021) & (US$ Million) Table 21. Latin America Physostigmine Sales (K Units) by Type (2016-2021) Table 22. Latin America Physostigmine Sales by Type (2016-2021) & (US$ Million) Table 23. Middle East and Africa Physostigmine Sales (K Units) by Type (2016-2021) Table 24. Middle East and Africa Physostigmine Sales by Type (2016-2021) & (US$ Million) Table 25. Global Physostigmine Sales by Company (2016-2021) & (K Units) Table 26. Global Physostigmine Sales Share by Company (2016-2021) Table 27. Global Physostigmine Revenue by Company (2016-2021) & (US$ Million) Table 28. Global Physostigmine Revenue Share by Company (2016-2021) Table 29. Global Market Physostigmine Price by Company (2016-2021) & (US$/Unit) Table 30. Global Physostigmine Top Manufacturers Manufacturing Base Distribution and Sales Area Table 31. Global Physostigmine Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Physostigmine as of 2020 Table 33. Date of Key Manufacturers Enter into Physostigmine Market Table 34. Key Manufacturers Physostigmine Product Type Table 35. Mergers & Acquisitions, Expansion Plans Table 36. Global Physostigmine Market Size Comparison by Region (US$ Million): 2016 VS 2021 VS 2027 Table 37. Global Physostigmine Sales by Region (2016-2021) & (K Units) Table 38. Global Physostigmine Sales Market Share in Volume by Region (2016-2021) Table 39. Global Physostigmine Sales by Region (2016-2021) & (US$ Million) Table 40. Global Physostigmine Sales Market Share in Value by Region (2016-2021) Table 41. Global Physostigmine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 42. Global Physostigmine Sales by Region (2022-2027) & (K Units) Table 43. Global Physostigmine Sales Market Share in Volume by Region (2022-2027) Table 44. Global Physostigmine Sales by Region (2022-2027) & (US$ Million) Table 45. Global Physostigmine Sales Market Share in Value by Region (2022-2027) Table 46. Global Physostigmine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2022-2027) Table 47. Global Physostigmine Sales by Application: 2016 VS 2021 VS 2027 (US$ Million) Table 48. Global Physostigmine Sales by Application (2016-2021) & (K Units) Table 49. Global Physostigmine Sales Market Share in Volume by Application (2016-2021) Table 50. Global Physostigmine Sales by Application (2016-2021) & (US$ Million) Table 51. Global Physostigmine Sales Market Share in Value by Application (2016-2021) Table 52. Global Physostigmine Price by Application (2016-2021) & (US$/Unit) Table 53. Global Physostigmine Sales by Application (2022-2027) & (K Units) Table 54. Global Physostigmine Sales Market Share in Volume by Application (2022-2027) Table 55. Global Physostigmine Sales by Application (2022-2027) & (US$ Million) Table 56. Global Physostigmine Sales Market Share in Value by Application (2022-2027) Table 57. Global Physostigmine Price by Application (2022-2027) & (US$/Unit) Table 58. North America Physostigmine Sales by Application (2016-2021) (K Units) Table 59. North America Physostigmine Sales by Application (2016-2021) & (US$ Million) Table 60. North America Physostigmine Sales Market Share in Value by Application in 2020 Table 61. Europe Physostigmine Sales by Application (2016-2021) (K Units) Table 62. Europe Physostigmine Sales by Application (2016-2021) & (US$ Million) Table 63. Europe Physostigmine Sales Market Share in Value by Application in 2020 Table 64. Asia-Pacific Physostigmine Sales by Application (2016-2021) (K Units) Table 65. Asia-Pacific Physostigmine Sales by Application (2016-2021) & (US$ Million) Table 66. Asia-Pacific Physostigmine Sales Market Share in Value by Application in 2020 Table 67. Latin America Physostigmine Sales by Application (2016-2021) (K Units) Table 68. Latin America Physostigmine Sales by Application (2016-2021) & (US$ Million) Table 69. Latin America Physostigmine Sales Market Share in Value by Application in 2020 Table 70. Middle East and Africa Physostigmine Sales by Application (2016-2021) (K Units) Table 71. Middle East and Africa Physostigmine Sales by Application (2016-2021) & (US$ Million) Table 72. Middle East and Africa Physostigmine Sales Market Share in Value by Application in 2020 Table 73. North America Physostigmine Sales by Country (2016-2021) & (K Units) Table 74. North America Physostigmine Sales Market Share in Volume by Country (2016-2021) Table 75. North America Physostigmine Sales by Country (2016-2021) & (US$ Million) Table 76. North America Physostigmine Sales Market Share in Value by Country (2016-2021) Table 77. North America Physostigmine Sales by Country (2022-2027) & (K Units) Table 78. North America Physostigmine Sales Market Share in Volume by Country (2022-2027) Table 79. North America Physostigmine Sales by Country (2022-2027) & (US$ Million) Table 80. North America Physostigmine Sales Market Share in Value by Country (2022-2027) Table 81. Europe Physostigmine Sales by Country (2016-2021) & (K Units) Table 82. Europe Physostigmine Sales Market Share in Volume by Country (2016-2021) Table 83. Europe Physostigmine Sales by Country (2016-2021) & (US$ Million) Table 84. Europe Physostigmine Sales Market Share in Value by Country (2016-2021) Table 85. Europe Physostigmine Sales by Country (2022-2027) & (K Units) Table 86. Europe Physostigmine Sales Market Share in Volume by Country (2022-2027) Table 87. Europe Physostigmine Sales by Country (2022-2027) & (US$ Million) Table 88. Europe Physostigmine Sales Market Share in Value by Country (2022-2027) Table 89. Asia-Pacific Physostigmine Sales by Region (2016-2021) & (K Units) Table 90. Asia-Pacific Physostigmine Sales Market Share in Volume by Region (2016-2021) Table 91. Asia-Pacific Physostigmine Sales by Region (2016-2021) & (US$ Million) Table 92. Asia-Pacific Physostigmine Sales Market Share in Value by Region (2016-2021) Table 93. Asia-Pacific Physostigmine Sales by Region (2022-2027) & (K Units) Table 94. Asia-Pacific Physostigmine Sales Market Share in Volume by Region (2022-2027) Table 95. Asia-Pacific Physostigmine Sales by Region (2022-2027) & (US$ Million) Table 96. Asia-Pacific Physostigmine Sales Market Share in Value by Region (2022-2027) Table 97. Latin America Physostigmine Sales by Country (2016-2021) & (K Units) Table 98. Latin America Physostigmine Sales Market Share in Volume by Country (2016-2021) Table 99. Latin America Physostigmine Sales by Country (2016-2021) & (US$ Million) Table 100. Latin America Physostigmine Sales Market Share in Value by Country (2016-2021) Table 101. Latin America Physostigmine Sales by Country (2022-2027) & (K Units) Table 102. Latin America Physostigmine Sales Market Share in Volume by Country (2022-2027) Table 103. Latin America Physostigmine Sales by Country (2022-2027) & (US$ Million) Table 104. Latin America Physostigmine Sales Market Share in Value by Country (2022-2027) Table 105. Middle East and Africa Physostigmine Sales by Country (2016-2021) & (K Units) Table 106. Middle East and Africa Physostigmine Sales Market Share in Volume by Country (2016-2021) Table 107. Middle East and Africa Physostigmine Sales by Country (2016-2021) & (US$ Million) Table 108. Middle East and Africa Physostigmine Sales Market Share in Value by Country (2016-2021) Table 109. Middle East and Africa Physostigmine Sales by Country (2022-2027) & (K Units) Table 110. Middle East and Africa Physostigmine Sales Market Share in Volume by Country (2022-2027) Table 111. Middle East and Africa Physostigmine Sales by Country (2022-2027) & (US$ Million) Table 112. Middle East and Africa Physostigmine Sales Market Share in Value by Country (2022-2027) Table 113. Alcon Corporation Information Table 114. Alcon Introduction and Business Overview Table 115. Alcon Physostigmine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 116. Alcon Physostigmine Product Table 117. Alcon Recent Development Table 118. Akorn Corporation Information Table 119. Akorn Introduction and Business Overview Table 120. Akorn Physostigmine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 121. Akorn Physostigmine Product Table 122. Akorn Recent Development Table 123. IFET Corporation Information Table 124. IFET Introduction and Business Overview Table 125. IFET Physostigmine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 126. IFET Physostigmine Product Table 127. IFET Recent Development Table 128. Merck Corporation Information Table 129. Merck Introduction and Business Overview Table 130. Merck Physostigmine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 131. Merck Physostigmine Product Table 132. Merck Recent Development Table 133. Hangzhou APIChem Corporation Information Table 134. Hangzhou APIChem Introduction and Business Overview Table 135. Hangzhou APIChem Physostigmine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 136. Hangzhou APIChem Physostigmine Product Table 137. Hangzhou APIChem Recent Development Table 138. Key Raw Materials Lists Table 139. Raw Materials Key Suppliers Lists Table 140. Physostigmine Market Trends Table 141. Physostigmine Market Drivers Table 142. Physostigmine Market Challenges Table 143. Physostigmine Market Restraints Table 144. Physostigmine Distributors List Table 145. Physostigmine Downstream Customers Table 146. Research Programs/Design for This Report Table 147. Key Data Information from Secondary Sources Table 148. Key Data Information from Primary Sources List of Figures Figure 1. Physostigmine Product Picture Figure 2. Global Physostigmine Market Size, 2016 VS 2021 VS 2027 (US$ Million) Figure 3. Global Physostigmine Market Size Status and Outlook (2016-2027) & (US$ Million) Figure 4. Global Physostigmine Sales Status and Outlook (2016-2027) & (K Units) Figure 5. Product Picture of Intravenous Figure 6. Global Intravenous Sales YoY Growth (2016-2021) & (K Units) Figure 7. Product Picture of Intramuscular Figure 8. Global Intramuscular Sales YoY Growth (2016-2021) & (K Units) Figure 9. Product Picture of Ophthalmic Figure 10. Global Ophthalmic Sales YoY Growth (2016-2021) & (K Units) Figure 11. Global Physostigmine Sales by Type (2016-2027) & (US$ Million) Figure 12. Global Physostigmine Sales Market Share in Volume by Type (2016-2021) Figure 13. Global Physostigmine Sales Market Share in Value by Type (2016-2021) Figure 14. Global Physostigmine Sales Market Share in Volume by Type (2022-2027) Figure 15. Global Physostigmine Sales Market Share in Value by Type (2022-2027) Figure 16. North America Physostigmine Sales Market Share in Volume by Type in 2020 Figure 17. North America Physostigmine Sales Market Share in Value by Type in 2020 Figure 18. Europe Physostigmine Sales Market Share in Volume by Type in 2020 Figure 19. Europe Physostigmine Sales Market Share in Value by Type in 2020 Figure 20. Asia-Pacific Physostigmine Sales Market Share in Volume by Type in 2020 Figure 21. Asia-Pacific Physostigmine Sales Market Share in Value by Type in 2020 Figure 22. Latin America Physostigmine Sales Market Share in Volume by Type in 2020 Figure 23. Latin America Physostigmine Sales Market Share in Value by Type in 2020 Figure 24. Middle East and Africa Physostigmine Sales Market Share in Volume by Type in 2020 Figure 25. Middle East and Africa Physostigmine Sales Market Share in Value by Type in 2020 Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Physostigmine Sales in 2020 Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Physostigmine Revenue in 2020 Figure 28. Physostigmine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 29. Product Picture of Hospital Figure 30. Global Hospital Sales YoY Growth (2016-2027) & (K Units) Figure 31. Product Picture of Drug Store Figure 32. Global Drug Store Sales YoY Growth (2016-2027) & (K Units) Figure 33. Global Physostigmine Sales by Application (2016-2027) & (US$ Million) Figure 34. Global Physostigmine Sales Market Share in Volume by Application (2016-2021) Figure 35. Global Physostigmine Sales Market Share in Value by Application (2016-2021) Figure 36. Global Physostigmine Sales Market Share in Volume by Application (2022-2027) Figure 37. North America Physostigmine Sales Market Share in Volume by Application in 2020 Figure 38. Latin America Physostigmine Sales Market Share in Value by Application in 2020 Figure 39. Middle East and Africa Physostigmine Sales Market Share in Value by Application in 2020 Figure 40. Key Raw Materials Price Figure 41. Physostigmine Manufacturing Cost Structure Figure 42. Physostigmine Industrial Chain Analysis Figure 43. Channels of Distribution Figure 44. Distributors Profiles Figure 45. Bottom-up and Top-down Approaches for This Report Figure 46. Data Triangulation Figure 47. Key Executives Interviewed

Alcon Akorn IFET Merck Hangzhou APIChem